Patent · US Active

Compositions and methods of treating facioscapulohumeral muscular dystrophy

US11999955B2 · kind B2 · utility

0Cited by
204References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2022
Grant dateJun 4, 2024
Priority date—
Expiry dateNov 4, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/35
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.